Efficacy of octreotide (Octrade) for prevention of pancreatitis after endoscopic retrograde cholangiopancreatography-Reference-Cited by-同舟云学术

Efficacy of octreotide (Octrade) for prevention of pancreatitis after endoscopic retrograde cholangiopancreatography

Published:2020-12-22 Issue:30 Volume:1 Page:30-36
ISSN:2078-5631
Container-title:Medical alphabet
language:
Short-container-title:Medicinskij alfavit

Author:

Krylova E. A.¹,Aleinik D. V.²

Affiliation:

1. On Clinic Dnipro

2. Clinical Emergency Hospital

Abstract

The article presents the results of a study of the effectiveness of the use of an inhibitor of pancreatic enzyme secretion of octreotide (Octrade) for the prevention of pancreatitis after endoscopic retrograde cholangiopancreatography (ERCP). It was shown that the administration of Octrade at a dose of 0.3 mg in 500 ml of 0.9 % NaCl by continuous intravenous infusion for 7 hours and then 0.1 mg of Octrade subcutaneously at 6 and 12 hours after the end of intravenous infusion significantly reduced the frequency of pancreatitis (4.0 % and 22.2 %; p < 0.05) and hyperamylasemia (8.0 % and 25.9 %; p < 0.05) after ERCP. It is concluded that Octrade is effective in preventing the development of pancreatitis and hyperamilasemia after ERCP.

Publisher

Alfmed LLC

Subject

Materials Chemistry,Economics and Econometrics,Media Technology,Forestry

Reference59 articles.

1. Иванов Ю. В. Фармако-экономические аспекты использования октреотида в профилактике и комплексном лечении острого послеоперационного панкреатита // РМЖ. 2005. № 26. C. 1781. https://www.rmj.ru/articles/obshchie-stati/Farmakoekonomicheskie_aspekty_ispolyzovaniya_oktreotida_v_profilaktike_i_kompleksnom_lechenii_ostrogo_posleoperacionnogo_pankreatita/

2. Попова М. А., Леонтьев А. С., Короткевич А. Г., Мерзляков М. В., Шестак И. С. Постманипуляционный панкреатит: актуальность проблемы, сложности диагностики и нерешенные проблемы // Политравма. 2018. № 3. C. 93–101.

3. Ahmed M, Kanotra R, Savani GT, et al. Utilization trends in inpatient endoscopic retrograde cholangiopancreatography (ERCP): A cross-sectional US experience // Endosc Int Open. 2017. V. 5 (4). E 261–E 271. DOI: 10.1055/s‑0043–102402.

4. Andriulli A., Leandro G., Federici T. et al. Prophylactic administration of somatostatin or gabexate does not prevent pancreatitis after ERCP: an updated meta-analysis // Gastrointest Endosc. 2007. V. 65. P. 624–632.

5. Andriulli A., Leandro G., Niro G. et al. Pharmacologic treatment can prevent pancreatic injury after ERCP: a meta-analysis // Gastrointest Endosc. 2000. V. 51. P. 1–7.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Профілактика та лікування панкреатиту після ендоскопічних втручань на жовчовивідних протоках;Шпитальна хірургія. Журнал імені Л. Я. Ковальчука;2023-07-25

2. Prevention of acute post-manipulation pancreatitis;Experimental and Clinical Gastroenterology;2023-05-25

3. Topical issues of prevention of acute postmanipulation pancreatitis;Experimental and Clinical Gastroenterology;2023-01-18